Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06144294 · ClinicalTrials.gov registry record · NA
Whole-Body Hyperthermia for Mood and Anxiety Disorders
A NA study, sponsored by Weill Medical College of Cornell University.
- Not yet
- Registry status
- NA
- Development phase
- 240
- Enrollment target
NCT06144294 is a NA study that has not yet begun recruiting, run by Weill Medical College of Cornell University. The registered enrollment target is 240 participants.
The verdict
NCT06144294, a NA study, has not yet begun recruiting, sponsored by Weill Medical College of Cornell University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
Study Summary
This study aims to examine the scientific mechanisms of whole-body hyperthermia (WBH), a novel, rapidly acting, single session antidepressant and anxiolytic therapy. It also aims to determine its feasibility and acceptability in women with postpartum depression (PPD). The study will enroll four cohorts of participants: healthy postpartum controls; postpartum women with PPD; healthy adult controls; and adults with major depressive disorder or anxiety disorders in a longitudinal protocol.
Interventions
- DIAGNOSTIC_TEST fMRI
- OTHER Whole-Body Hyperthermia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2028-06 |
| Est. Completion | 2032-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06144294
The ClinicalTrials.gov registry entry for NCT06144294 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which fMRI is the first listed.
NCT06144294 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06144294 about?
NCT06144294 is a clinical study titled "Whole-Body Hyperthermia for Mood and Anxiety Disorders". This study aims to examine the scientific mechanisms of whole-body hyperthermia (WBH), a novel, rapidly acting, single session antidepressant and anxiolytic therapy. It also aims to determine its feasibility and acceptability in women with postpartum depression (PPD). The study will enroll four coho...
What is the current status of trial NCT06144294?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2028-06. Estimated completion is 2032-12.
What interventions are being tested in trial NCT06144294?
The interventions under investigation include: fMRI (DIAGNOSTIC_TEST), Whole-Body Hyperthermia (OTHER).
Who is sponsoring clinical trial NCT06144294?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.